|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: KING PHARMACEUTICALS INC, 10-Q, EX-3.1, 2000-08-14 |
Next: U S TIMBERLANDS KLAMATH FALLS LLC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF KING PHARMACEUTICALS FOR THE SIX MONTHS ENDED JUNE 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 73,554
<SECURITIES> 0
<RECEIVABLES> 91,749
<ALLOWANCES> (2,214)
<INVENTORY> 60,101
<CURRENT-ASSETS> 246,167
<PP&E> 114,518
<DEPRECIATION> (15,724)
<TOTAL-ASSETS> 902,219
<CURRENT-LIABILITIES> 95,124
<BONDS> 150,000
0
0
<COMMON> 0
<OTHER-SE> 476,607
<TOTAL-LIABILITY-AND-EQUITY> 902,219
<SALES> 171,713
<TOTAL-REVENUES> 194,585
<CGS> 52,838
<TOTAL-COSTS> 147,812
<OTHER-EXPENSES> (179)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 24,156
<INCOME-PRETAX> 23,706
<INCOME-TAX> 15,706
<INCOME-CONTINUING> 15,706
<DISCONTINUED> 0
<EXTRAORDINARY> 4,685
<CHANGES> 0
<NET-INCOME> 3,315
<EPS-BASIC> 0.04
<EPS-DILUTED> 0.04
</TABLE>
|
|